Tofacitinib or Adalimumab versus Placebo in Rheumatoid Arthritis.
van Vollenhoven, Ronald F.; Fleischmann, Roy; Cohen, Stanley; Lee, Eun Bong; García Meijide, Juan A.; Wagner, Sylke; Forejtova, Sarka; Zwillich, Samuel H.; Gruben, David; Koncz, Tamas; Wallenstein, Gene V.; Krishnaswami, Sriram; Bradley, John D.; Wilkinson, Bethanie; New England Journal of Medicine, 2012, vol. 367, issue 6, p 508, ISSN 00284793. ISBN 00284793.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef